Yatin Suneja
Stock Analyst at Guggenheim
(2.24)
# 2,657
Out of 4,829 analysts
130
Total ratings
39.02%
Success rate
-5.36%
Average return
Main Sectors:
Stocks Rated by Yatin Suneja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARGX argenx SE | Maintains: Buy | $1,100 → $1,065 | $560.90 | +89.87% | 10 | May 9, 2025 | |
| GHRS GH Research | Maintains: Buy | $32 → $29 | $10.16 | +185.43% | 1 | May 9, 2025 | |
| ANAB AnaptysBio | Maintains: Buy | $52 → $54 | $20.03 | +169.60% | 12 | May 6, 2025 | |
| NBIX Neurocrine Biosciences | Maintains: Buy | $155 → $165 | $120.43 | +37.01% | 5 | May 6, 2025 | |
| PHAT Phathom Pharmaceuticals | Maintains: Buy | $18 → $12 | $3.15 | +280.95% | 4 | May 2, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $940 → $810 | $575.63 | +40.72% | 6 | May 1, 2025 | |
| CABA Cabaletta Bio | Reiterates: Buy | $23 | $1.29 | +1,682.95% | 3 | Apr 1, 2025 | |
| ZURA Zura Bio | Reiterates: Buy | $15 | $1.24 | +1,109.68% | 2 | Mar 26, 2025 | |
| IFRX InflaRx | Maintains: Buy | $7 → $10 | $1.67 | +498.80% | 5 | Mar 26, 2025 | |
| LRMR Larimar Therapeutics | Reiterates: Buy | $26 | $2.08 | +1,150.00% | 4 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.72 | +870.87% | 1 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $14.55 | - | 8 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $84 | $20.08 | +318.33% | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $9.74 | +362.01% | 3 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.69 | - | 2 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $2.53 | - | 3 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $45 | $8.00 | +462.50% | 3 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 | $17.52 | +14.16% | 6 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.66 | - | 2 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $15.78 | - | 2 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $65 | $14.93 | +335.37% | 1 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $155 → $170 | $38.42 | +342.48% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $5.25 | +509.52% | 1 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.88 | - | 3 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $6.40 | +681.25% | 1 | Apr 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $90 | $20.18 | +345.99% | 5 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $125 | $110.16 | +13.47% | 8 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $16 | $10.99 | +45.59% | 2 | Nov 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $77 | $40.18 | +91.64% | 3 | Nov 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.48 | - | 3 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $35.85 | +36.68% | 2 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $55 | $5.85 | +840.17% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $270 → $350 | $124.40 | +181.35% | 3 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.75 | - | 5 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.40 | - | 3 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $11.89 | +101.85% | 1 | May 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $34 | $67.53 | -49.65% | 2 | Jan 14, 2020 |
argenx SE
May 9, 2025
Maintains: Buy
Price Target: $1,100 → $1,065
Current: $560.90
Upside: +89.87%
GH Research
May 9, 2025
Maintains: Buy
Price Target: $32 → $29
Current: $10.16
Upside: +185.43%
AnaptysBio
May 6, 2025
Maintains: Buy
Price Target: $52 → $54
Current: $20.03
Upside: +169.60%
Neurocrine Biosciences
May 6, 2025
Maintains: Buy
Price Target: $155 → $165
Current: $120.43
Upside: +37.01%
Phathom Pharmaceuticals
May 2, 2025
Maintains: Buy
Price Target: $18 → $12
Current: $3.15
Upside: +280.95%
Regeneron Pharmaceuticals
May 1, 2025
Maintains: Buy
Price Target: $940 → $810
Current: $575.63
Upside: +40.72%
Cabaletta Bio
Apr 1, 2025
Reiterates: Buy
Price Target: $23
Current: $1.29
Upside: +1,682.95%
Zura Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $15
Current: $1.24
Upside: +1,109.68%
InflaRx
Mar 26, 2025
Maintains: Buy
Price Target: $7 → $10
Current: $1.67
Upside: +498.80%
Larimar Therapeutics
Mar 25, 2025
Reiterates: Buy
Price Target: $26
Current: $2.08
Upside: +1,150.00%
Mar 21, 2025
Reiterates: Buy
Price Target: $7
Current: $0.72
Upside: +870.87%
Mar 20, 2025
Reiterates: Buy
Price Target: n/a
Current: $14.55
Upside: -
Mar 12, 2025
Reiterates: Buy
Price Target: $84
Current: $20.08
Upside: +318.33%
Mar 12, 2025
Reiterates: Buy
Price Target: $45
Current: $9.74
Upside: +362.01%
Mar 10, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.69
Upside: -
Jan 24, 2025
Reiterates: Buy
Price Target: n/a
Current: $2.53
Upside: -
Jan 3, 2025
Upgrades: Buy
Price Target: $45
Current: $8.00
Upside: +462.50%
Jan 3, 2025
Downgrades: Neutral
Price Target: $20
Current: $17.52
Upside: +14.16%
Dec 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.66
Upside: -
Dec 11, 2024
Reiterates: Buy
Price Target: n/a
Current: $15.78
Upside: -
Oct 25, 2024
Maintains: Buy
Price Target: $50 → $65
Current: $14.93
Upside: +335.37%
Aug 14, 2024
Maintains: Buy
Price Target: $155 → $170
Current: $38.42
Upside: +342.48%
Jul 23, 2024
Initiates: Buy
Price Target: $32
Current: $5.25
Upside: +509.52%
May 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.88
Upside: -
Apr 29, 2024
Initiates: Buy
Price Target: $50
Current: $6.40
Upside: +681.25%
Feb 27, 2024
Maintains: Buy
Price Target: $72 → $90
Current: $20.18
Upside: +345.99%
Feb 21, 2024
Maintains: Buy
Price Target: $110 → $125
Current: $110.16
Upside: +13.47%
Nov 15, 2023
Maintains: Buy
Price Target: $17 → $16
Current: $10.99
Upside: +45.59%
Nov 15, 2023
Maintains: Buy
Price Target: $70 → $77
Current: $40.18
Upside: +91.64%
Jul 17, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.48
Upside: -
Jun 15, 2023
Reiterates: Buy
Price Target: $49
Current: $35.85
Upside: +36.68%
May 18, 2023
Maintains: Buy
Price Target: $52 → $55
Current: $5.85
Upside: +840.17%
May 1, 2023
Upgrades: Buy
Price Target: $270 → $350
Current: $124.40
Upside: +181.35%
Jan 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $6.75
Upside: -
Oct 14, 2022
Downgrades: Neutral
Price Target: n/a
Current: $0.40
Upside: -
May 31, 2022
Initiates: Buy
Price Target: $24
Current: $11.89
Upside: +101.85%
Jan 14, 2020
Maintains: Buy
Price Target: $29 → $34
Current: $67.53
Upside: -49.65%